COVID – 19: Control it or it will Control You

α
Dr. C M Marya
Dr. C M Marya
σ
Dr. Shilpa Arora
Dr. Shilpa Arora
ρ
Dr. Ruchi Nagpal
Dr. Ruchi Nagpal
Ѡ
Dr. Sakshi Kataria
Dr. Sakshi Kataria
¥
Dr. Pratibha Taneja
Dr. Pratibha Taneja
§
Dr. Vishal Juneja
Dr. Vishal Juneja

Send Message

To: Author

COVID – 19: Control it or it will Control You

Article Fingerprint

ReserarchID

82Q1R

COVID – 19: Control it or it will Control You Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

In 2019, a new virus named severe acute respiratory syndrome coronavirus 2 emerged in Wuhan City of Hubei Province of China causing and exerted a massive toll over the world. By World Health Organization, it was subsequently named COVID -19 (Corona virus disease). It is considered as a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Within months after its emergence in China, it had affected more than seven lakhs lives and caused more than thirty thousand deaths. The general clinical symptoms associated with COVID -19 patients include fever, dry cough, generalized body pain and shortness of breath. Its high transmission potential highlighted the need for a coordinated global response to contain such disease threats. Treatment is essentially symptomatic and primary intervention being used is social distancing. Hence special attention and efforts should be implemented to control the current outbreaks. The present review was constructed to elaborate the Corona virus disease and to investigate the most recent trend in India.

References

24 Cites in Article
  1. C Wang,P Horby,F Hayden,G Gao (2020). A novel coronavirus outbreak of global health concern.
  2. P Zhou,X Yang,X Wang (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin.
  3. Hongzhou Lu,Charles Stratton,Yi‐wei Tang (2020). Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle.
  4. (2020). Early Epidemiological and Clinical Characteristics of 28 Cases of Coronavirus Disease in South Korea.
  5. Didier Raoult,Alimuddin Zumla,Franco Locatelli,Giuseppe Ippolito,Guido Kroemer (2020). Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses.
  6. W Wang,J Tang,F Wei (2020). Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China.
  7. Peng Wu,Xinxin Hao,Eric Lau,Jessica Wong,Kathy Leung,Joseph Wu,Benjamin Cowling,Gabriel Leung (2020). Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020.
  8. R Lu,X Zhao,J Li (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
  9. Stanley Perlman (2020). Another Decade, Another Coronavirus.
  10. C Huang,Y Wang,X Li (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
  11. Qun Li (2020). An Outbreak of NCIP (2019-nCoV) Infection in China — Wuhan, Hubei Province, 2019−2020.
  12. Camilla Rothe,Mirjam Schunk,Peter Sothmann,Gisela Bretzel,Guenter Froeschl,Claudia Wallrauch,Thorbjörn Zimmer,Verena Thiel,Christian Janke,Wolfgang Guggemos,Michael Seilmaier,Christian Drosten,Patrick Vollmar,Katrin Zwirglmaier,Sabine Zange,Roman Wölfel,Michael Hoelscher (2020). Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany.
  13. Q Li,X Guan,P Wu (2020). Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.
  14. E Mahase (2020). China Coronavirus: what do we know so far?.
  15. L Ren,Y Wang,Z Wu (2020). Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Novel Coronavirus Severe Pneumonia.
  16. W Carlos,Charles Dela Cruz,Bin Cao,Susan Pasnick,Shazia Jamil (2020). COVID-19 Disease due to SARS-CoV-2 (Novel Coronavirus).
  17. Zhi-Min Chen,Jun-Fen Fu,Qiang Shu,Ying-Hu Chen,Chun-Zhen Hua,Fu-Bang Li,Ru Lin,Lan-Fang Tang,Tian-Lin Wang,Wei Wang,Ying-Shuo Wang,Wei-Ze Xu,Zi-Hao Yang,Sheng Ye,Tian-Ming Yuan,Chen-Mei Zhang,Yuan-Yuan Zhang (2020). Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus.
  18. Nanshan Chen,Min Zhou,Xuan Dong,Jieming Qu,Fengyun Gong,Yang Han,Yang Qiu,Jingli Wang,Ying Liu,Yuan Wei,Jia'an Xia,Ting Yu,Xinxin Zhang,Li Zhang (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
  19. Sukhyun Ryu,Byung Chun (2020). An interim review of the epidemiological characteristics of 2019 novel coronavirus.
  20. Hongzhou Lu (2020). Drug treatment options for the 2019-new coronavirus (2019-nCoV).
  21. M Cascella,M Rajnik,A Cuomo (2020). Features, Evaluation and Treatment Coronavirus (COVID-19).
  22. Jianjun Gao,Zhenxue Tian,Xu Yang (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
  23. Manli Wang,Ruiyuan Cao,Leike Zhang,Xinglou Yang,Jia Liu,Mingyue Xu,Zhengli Shi,Zhihong Hu,Wu Zhong,Gengfu Xiao (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
  24. Sanket Kulkarni,Himanshu Chauhan (2020). COVID-19 in Different Age Groups of Children: Initial Impression from Integrated Disease Surveillance Programme (IDSP) under National Centre for Disease Control (NCDC).

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Dr. C M Marya. 2020. \u201cCOVID – 19: Control it or it will Control You\u201d. Global Journal of Medical Research - J: Dentistry & Otolaryngology GJMR-J Volume 20 (GJMR Volume 20 Issue J4): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-J Classification: NLMC Code: WU 113
Version of record

v1.2

Issue date

June 10, 2020

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 2391
Total Downloads: 1183
2026 Trends
Related Research

Published Article

In 2019, a new virus named severe acute respiratory syndrome coronavirus 2 emerged in Wuhan City of Hubei Province of China causing and exerted a massive toll over the world. By World Health Organization, it was subsequently named COVID -19 (Corona virus disease). It is considered as a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Within months after its emergence in China, it had affected more than seven lakhs lives and caused more than thirty thousand deaths. The general clinical symptoms associated with COVID -19 patients include fever, dry cough, generalized body pain and shortness of breath. Its high transmission potential highlighted the need for a coordinated global response to contain such disease threats. Treatment is essentially symptomatic and primary intervention being used is social distancing. Hence special attention and efforts should be implemented to control the current outbreaks. The present review was constructed to elaborate the Corona virus disease and to investigate the most recent trend in India.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

COVID – 19: Control it or it will Control You

Dr. C M Marya
Dr. C M Marya
Dr. Shilpa Arora
Dr. Shilpa Arora
Dr. Ruchi Nagpal
Dr. Ruchi Nagpal
Dr. Sakshi Kataria
Dr. Sakshi Kataria
Dr. Pratibha Taneja
Dr. Pratibha Taneja
Dr. Vishal Juneja
Dr. Vishal Juneja

Research Journals